Kevin Campbell

New understanding of how the alpha-dystroglycan protein is glycosylated (sugar-coated) may have relevance for treating some forms of congenital and limb-girdle muscular dystrophy

posted on August 13, 2013 - 3:19pm
Glycosylation — "sugar-coating" — of the muscle protein alpha-dystroglycan is known to be a crucial part of muscle function. Without sufficient glycosylation, alpha-dystroglycan doesn't stick well to other proteins, and an important linkage between muscle fibers and their surroundings is disrupted.

Investigators have developed lab mice likely to advance understanding of the fukutin-deficient disorders Fukuyama congenital muscular dystrophy and type 2M limb-girdle muscular dystrophy

posted on October 9, 2012 - 5:00am
By disrupting the fukutin gene at different time points in mice embryo, researchers have been able to develop research models of two types of human muscle disease: Fukuyama congenital muscular dystrophy (Fukuyama CMD)  and type 2M limb-girdle muscular dystrophy (LGMD2M).
posted on July 1, 2009 - 3:09pm
QUEST Vol. 16, No. 3
Two longtime MDA grantees receive prestigious award On May 3, 2009, molecular biologist Louis Kunkel at Children’s Hospital in Boston and Harvard University, and biophysicist Kevin Campbell at the University of Iowa, received the prestigious March of Dimes Prize in Developmental Biology. The prize includes a $250,000 cash award.

Two longtime MDA research grantees receive prestigious award for their work in muscle biology

posted on May 7, 2009 - 10:45am
On May 3, 2009, molecular biologist Louis Kunkel at Children's Hospital in Boston and Harvard University, and biophysicist Kevin Campbell at the University of Iowa, received the prestigious March of Dimes Prize in Developmental Biology. The prize includes a $250,000 cash award.